ArticleBritish journal of cancer2014

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.

N Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.